Hold Sun Pharma , says Sudarshan Sukhani of s2analytics.com.
Sukhani told CNBC-TV18, "Sun Pharma is a dream stock. It rallied, made new highs and never came down. Now like most other stocks that are offering interesting possibilities, Sun Pharma is in a consolidation but it seems reasonable to assume that Sun Pharma's consolidation will eventually breakout on the upside. Yesterday it did so."
He further added, "Once this consolidation has broken out then we have Rs 540 level after which it starts making new highs. Yesterday we had a breakout from a consolidation, we should see follow through today and eventually new highs. So it's one of the better stocks to hold on to. So a risk in buying it is in terms of quality is very low. So no risk idea, ready to make new highs, outperformer, I would say look at it."
The company's trailing 12-month (TTM) EPS was at Rs 13.36 per share. (Sep, 2011). The stock's price-to-earnings (P/E) ratio was 38.63. The latest book value of the company is Rs 64.51 per share. At current value, the price-to-book value of the company was 8. The dividend yield of the company was 0.68%.
